Voneseals Technology (Shanghai) Inc. (SHE:301161)
24.97
-0.79 (-3.07%)
Nov 12, 2026, 3:04 PM CST
SHE:301161 Revenue
Voneseals Technology (Shanghai) had revenue of 225.62M CNY in the quarter ending September 30, 2026, with 21.12% growth. This brings the company's total for the last twelve months to 867.45M, up 12.55% year-over-year. In the year 2025, Voneseals Technology (Shanghai) had annual revenue of 768.92M with 7.46% growth. That makes Voneseals Technology (Shanghai) the 20,739th largest company in the world by revenue and 3,809th in China.
Revenue (ttm)
867.45M
Revenue Growth
+12.55%
P/S Ratio
3.45
Revenue / Employee
1.26M
Employees
691
Market Cap
3.00B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHE:301161 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 768.92M | 53.37M | 7.46% |
| Dec 31, 2024 | 715.55M | 352.36M | 97.02% |
| Dec 31, 2023 | 363.20M | 22.76M | 6.69% |
| Jan 1, 2023 | 340.43M | -70.25M | -17.11% |
| Jan 1, 2022 | 410.68M | 5.64M | 1.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenyang Chemical | 6.37B |
| Zhejiang Huakang Pharmaceutical | 4.92B |
| Shaanxi Xinghua Chemistry Co.,Ltd | 4.22B |
| Dymatic Chemicals,Inc. | 3.61B |
| Changhua Chemical Technology | 3.33B |
| Kaili Catalyst & New Materials | 2.91B |
| Shanghai Titan Scientific | 2.63B |
| Zhejiang Jianye Chemical | 2.07B |